| scholarly article | Q13442814 |
| P2093 | author name string | Xiaofei Li | |
| Liwen Liu | |||
| Yongxin Chen | |||
| Lianqing Lou | |||
| Yongtao Hu | |||
| Lina Sheng | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis | Q26740313 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals | Q30241078 | ||
| Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force | Q30241360 | ||
| MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase | Q34687185 | ||
| Cancer risk in HBV patients with statin and metformin use: a population-based cohort study. | Q36152361 | ||
| Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis. | Q36334385 | ||
| Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. | Q36505496 | ||
| Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. | Q37029796 | ||
| Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase | Q37294374 | ||
| Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. | Q37745129 | ||
| Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis | Q38051955 | ||
| Hepatitis B virus infection and metabolic syndrome: fact or fiction? | Q38236996 | ||
| Statins are potential anticancerous agents (review). | Q38326767 | ||
| Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression | Q39328904 | ||
| Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma | Q39903453 | ||
| Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study. | Q40285529 | ||
| Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. | Q40468893 | ||
| Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis. | Q40699088 | ||
| Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. | Q41109284 | ||
| Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection | Q42990281 | ||
| Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection | Q45360202 | ||
| Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis | Q45909685 | ||
| Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation | Q51888144 | ||
| The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis | Q53395385 | ||
| Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma | Q57187387 | ||
| The impact of antiviral therapy on hepatocellular carcinoma epidemiology | Q57301376 | ||
| Hepatocellular carcinoma | Q58020832 | ||
| Epidemiology and Management of Hepatocellular Carcinoma | Q58118311 | ||
| Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma | Q59352351 | ||
| Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis | Q88596294 | ||
| Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B | Q90297451 | ||
| Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis | Q91124532 | ||
| Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms | Q91318927 | ||
| Review article: new therapeutic interventions for advanced hepatocellular carcinoma | Q91354822 | ||
| Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B | Q92438593 | ||
| Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population | Q92700702 | ||
| Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction | Q93099771 | ||
| P433 | issue | 1 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| Hepatitis C virus | Q708693 | ||
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 98 | |
| P577 | publication date | 2020-04-09 | |
| P1433 | published in | BMC Gastroenterology | Q15759922 |
| P1476 | title | Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis | |
| P478 | volume | 20 |
Search more.